Engelhard VH - Search Results

1

Immunomodulation of intracranial melanoma in response to blood-tumor barrier opening with focused ultrasound.

Curley CT, Stevens AD, Mathew AS, Stasiak K, Garrison WJ, Miller GW, Sheybani ND, Engelhard VH, Bullock TNJ, Price RJ. Curley CT, et al. Among authors: engelhard vh. Theranostics. 2020 Jul 11;10(19):8821-8833. doi: 10.7150/thno.47983. eCollection 2020. Theranostics. 2020. PMID: 32754281 Free PMC article.

2

Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells.

Bullock TN, Mullins DW, Engelhard VH. Bullock TN, et al. Among authors: engelhard vh. J Immunol. 2003 Feb 15;170(4):1822-9. doi: 10.4049/jimmunol.170.4.1822. J Immunol. 2003. PMID: 12574347

3

Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control.

Mullins DW, Sheasley SL, Ream RM, Bullock TN, Fu YX, Engelhard VH. Mullins DW, et al. Among authors: engelhard vh. J Exp Med. 2003 Oct 6;198(7):1023-34. doi: 10.1084/jem.20021348. J Exp Med. 2003. PMID: 14530375 Free PMC article.

4

Incomplete differentiation of antigen-specific CD8 T cells in tumor-draining lymph nodes.

Hargadon KM, Brinkman CC, Sheasley-O'neill SL, Nichols LA, Bullock TN, Engelhard VH. Hargadon KM, et al. Among authors: engelhard vh. J Immunol. 2006 Nov 1;177(9):6081-90. doi: 10.4049/jimmunol.177.9.6081. J Immunol. 2006. PMID: 17056534

5

Strategies and challenges in eliciting immunity to melanoma.

Ferguson AR, Nichols LA, Zarling AL, Thompson ED, Brinkman CC, Hargadon KM, Bullock TN, Engelhard VH. Ferguson AR, et al. Among authors: engelhard vh. Immunol Rev. 2008 Apr;222:28-42. doi: 10.1111/j.1600-065X.2008.00620.x. Immunol Rev. 2008. PMID: 18363993 Free PMC article.

6

The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice.

Bullock TN, Colella TA, Engelhard VH. Bullock TN, et al. Among authors: engelhard vh. J Immunol. 2000 Mar 1;164(5):2354-61. doi: 10.4049/jimmunol.164.5.2354. J Immunol. 2000. PMID: 10679070

7

Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use.

Engelhard VH, Bullock TN, Colella TA, Mullins DW. Engelhard VH, et al. Cancer J. 2000 May;6 Suppl 3:S272-80. Cancer J. 2000. PMID: 10874498 Review.

8

Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy.

Engelhard VH, Bullock TN, Colella TA, Sheasley SL, Mullins DW. Engelhard VH, et al. Immunol Rev. 2002 Oct;188:136-46. doi: 10.1034/j.1600-065x.2002.18812.x. Immunol Rev. 2002. PMID: 12445287 Review.

9

Immunity to melanoma antigens: from self-tolerance to immunotherapy.

Slingluff CL Jr, Chianese-Bullock KA, Bullock TN, Grosh WW, Mullins DW, Nichols L, Olson W, Petroni G, Smolkin M, Engelhard VH. Slingluff CL Jr, et al. Among authors: engelhard vh. Adv Immunol. 2006;90:243-95. doi: 10.1016/S0065-2776(06)90007-8. Adv Immunol. 2006. PMID: 16730266 Review.

10

Differential Expression of CD49a and CD49b Determines Localization and Function of Tumor-Infiltrating CD8⁺ T Cells.

Melssen MM, Lindsay RS, Stasiak K, Rodriguez AB, Briegel AM, Cyranowski S, Rutkowski MR, Conaway MR, Melief CJM, van der Burg SH, Eyo U, Slingluff CL Jr, Engelhard VH. Melssen MM, et al. Among authors: engelhard vh. Cancer Immunol Res. 2021 May;9(5):583-597. doi: 10.1158/2326-6066.CIR-20-0427. Epub 2021 Feb 22. Cancer Immunol Res. 2021. PMID: 33619119 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters